Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2816376
Reference Type
Journal Article
Title
MASS SPECTRAL FRAGMENTATION PATHWAYS OF PHTHALATE ESTERS BY GAS CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
Author(s)
Yin, P; Chen, H; Liu, Xin; Wang, Q; Jiang, Y; Pan, R
Year
2014
Is Peer Reviewed?
Yes
Journal
Analytical Letters
ISSN:
0003-2719
EISSN:
1532-236X
Volume
47
Issue
9
Page Numbers
1579-1588
DOI
10.1080/00032719.2013.879658
Web of Science Id
WOS:000337357600011
Abstract
Gas chromatography-tandem mass spectrometry was applied to study the mass spectral fragmentation of phthalate esters. The base peaks of phthalate esters with alkyl side chains (except dimethyl phthalate) were m/z 149, indicating that their fragmentation pathways were similar. The base peaks of benzyl butyl phthalate and dibutoxyethyl phthalate were also at m/z 149. Because of the presence of benzyl groups and butoxy groups in the side chains, their mass spectral fragmentation pathways were different from those of phthalate esters with alkyl side chains. The base peaks of dimethyl phthalate and diphenyl phthalate were m/z 163 and m/z 225, respectively, which corresponded to the fragments produced by alpha-cleavage of their molecular ion peaks. The base peaks of dimethoxyethyl phthalate and diethoxyethyl phthalate were m/z 59 and m/z 72, respectively, which corresponded to fragments produced by McLafferty rearrangement of their molecular ions. The fragmentation pathways provide fundamental information for the determination of phthalate esters and their metabolites.
Keywords
Fragmentation pathway; Gas chromatography-tandem mass spectrometry; Phthalate esters
Tags
IRIS
•
BBP (Butyl benzyl phthalate)
Literature Search
Litsearch April 2014 - February 2015
WOS
Excluded: No Primary Data on Health Effects
Measurement methods
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity